Research analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a report issued on Tuesday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Performance
Shares of MLSS stock opened at $0.57 on Tuesday. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.35. The firm has a market capitalization of $43.67 million, a PE ratio of -5.70 and a beta of 0.97. The stock’s 50-day simple moving average is $0.66 and its 200-day simple moving average is $0.72.
Milestone Scientific (NYSE:MLSS – Get Free Report) last posted its quarterly earnings results on Friday, March 29th. The company reported ($0.03) EPS for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%. The company had revenue of $2.26 million during the quarter.
Institutional Inflows and Outflows
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical.
Read More
- Five stocks we like better than Milestone Scientific
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- United Airlines Soars on Earnings Beat
- Bank Stocks – Best Bank Stocks to Invest In
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Where to Find Earnings Call Transcripts
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.